MaxCyte Inc
Change company Symbol lookup
Select an option...
MXCT MaxCyte Inc
RYN Rayonier Inc
AGM-E Federal Agricultural Mortgage Corp
KEX Kirby Corp
GM General Motors Co
F Ford Motor Co
MSFT Microsoft Corp
TWTR Twitter Inc
CCL Carnival Corp
ARKW ARK Next Generation Internet ETF

Health Care : Biotechnology | Small Cap Growth
Company profile

MaxCyte, Inc. is a commercial cell engineering company. The Company is focused on providing enabling platform technologies to advance cell-based research and development, as well as next-generation cell therapeutic discovery, development and commercialization. The Company has developed and commercialized its Flow Electroporation platform, which facilitates complex engineering of a variety of cells. Its ExPERT platform is based on its Flow Electroporation technology, which has been designed to address the cell therapy market and can be utilized across the continuum of the high-growth cell therapy sector, from discovery and development through commercialization of next-generation, cell-based medicines. Its ExPERT platform consists of three instruments, which are known as the ATx, STx and GTx. The Company has also developed CARMA, a therapeutic platform based on transfecting mRNA into unstimulated cells for the development of immune cell therapies.

Closing Price
Day's Change
0.10 (1.73%)
B/A Size
Day's High
Day's Low

10-day average volume:

Upcoming Events

MXCT's fiscal year ends in December
There are no upcoming events for MXCT

Past Earnings

This page reports .
DateEvent descriptionEarnings per
share actual
estimate range
Previous year's
August 10, 2022Q2 2022 Earnings Release-$0.08-$0.09 to -$0.07-$0.05
May 9, 2022Q1 2022 Earnings Release-$0.04-$0.07 to -$0.04--
March 22, 2022Q4 2021 Earnings Release-$0.05-$0.08 to -$0.02--
November 10, 2021Q3 2021 Earnings Release-$0.03-$0.07 to -$0.02--
September 13, 2021Q2 2021 Earnings Release-$0.05-$0.08 to -$0.05--

Earnings Calendar and Events Data provided by |Terms of Use| © 2022 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

, , , Copyright © 2022. All rights reserved.

Reuters content is the intellectual property of Reuters. Any copying, republication or redistribution of Reuters content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Reuters. Reuters is not liable for any errors or delays in content, or for any actions taken in reliance on any content. Reuters, Reuters Logo and the Sphere Logo are trademarks and registered trademarks of the Reuters Group of companies around the world.

Data is provided for information purposes only and is not intended for trading purposes. Reuters shall not be liable for any errors or delay in the content, or for any action taken in reliance on any content. The RIC or Reuters Instrument Code set has been developed and maintained by Reuters and is the intellectual property of Reuters.